Heinz Wiendl
@hwiendl
Followers
352
Following
37
Media
6
Statuses
48
Joined July 2015
đ âKI ersetzt keine Ărztinnen oder Ărzteâ â mein Interview im Handelsblatt @handelsblatt Ăźber Prof. ValmedÂŽ:.đ§ CE-zertifizierte KI zur UnterstĂźtzung klinischer Entscheidungen.âď¸ Qualität & Sicherheit im Fokus.đ Artikel:
handelsblatt.com
Der Neurologe Heinz Wiendl hat Prof. Valmed mitentwickelt. Wie die KI als Medizinprodukt in der Praxis helfen kann, wie sie mit Quatschfragen umgeht und ob der AI Act ihm Sorge bereitet.
0
0
0
đ¨ Paradigm shift in #MultipleSclerosis đ¨.New study in Nature Medicine shows MS is not fixed subtypes but a dynamic continuum of states across 4 dimensions: disability, brain damage, relapses & silent inflammation. đ Read: #MS #Neurology #AI
2
32
81
Blazing-fast image creation â using just your voice. Try Grok Imagine.
278
546
3K
New Responsibility. I am honored to announce that I will be taking on a new role as the Chair at the Klinik fßr Neurologie und Neurophysiologie at #UniversitätsklinikumFreiburg starting October 1, 2024. It is a privilege to join such a distinguished institution!.
4
0
19
RT @ISNI_neuro: #WEARENEUROIMMUNOLOGY #ISNI: @hwiendl just had the pleasure of presenting the five hottest developments in neuroimmunologyâŚ.
0
2
0
RT @uni_muenster: SFB/CRC-TR 128 International Symposium: Multiple sclerosis and related disorders in 2024: Past, present, and future. ApriâŚ.
0
2
0
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories | Science Translational Medicine
science.org
Three discrete immunological endophenotypes in early multiple sclerosis correlate with distinct disease trajectories and treatment responses.
2
8
32
RT @isabellacueto: Multiple sclerosis is a lot of different things. So, could there be distinct subtypes of the disease? A new study from @âŚ.
statnews.com
Multiple sclerosis went from an untreatable disease to a known, druggable condition in less than 40 years. Now a study finds subtypes that may benefit from different courses of treatment.
0
11
0
Finally: the German Myasthenia gravis guidelines now are released and published in english language and therefore are more globally readable and available! With the best wishes for a peaceful and conciliatory 2024!
pubmed.ncbi.nlm.nih.gov
Myasthenia gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS), and congenital myasthenic syndromes (CMS) represent an etiologically heterogeneous group of (very) rare chronic diseases. MG and LEMS...
1
0
9
RT @ScienceTM: Fresh data from trials of therapies that target immune #CellTraffickingâas well as biomaterial-based scientific projectsâisâŚ.
0
3
0
RT @ISNI_neuro: ISNI officers strongly condemn the terrorist attack perpetrated by Hamas in Israel. We express our solidarity to all the ciâŚ.
0
8
0
RT @ISNI_neuro: Due date for applications for the #WeAreNeuroimmunology Mid-Career Awards is May 30 2023 11:59 pm CET. #ISNI aims to recognâŚ.
0
6
0
Bruton Tyrosine Kinase inhibitors go strong in Multiple sclerosis: an unprecedented situation to have FOUR parallel programs already in Phase III. This review summarises why there is so much excitement and maybe promise for the field:
pubmed.ncbi.nlm.nih.gov
Current therapies for multiple sclerosis (MS) reduce both relapses and relapse-associated worsening of disability, which is assumed to be mainly associated with transient infiltration of peripheral...
0
1
20
Leucocyte trafficking inhibition to modulate neuroinflammation: is MCAM a next generation target (and more clever than Natalizumab)? A commentary on novel findings and strategic thoughts around this:
pubmed.ncbi.nlm.nih.gov
This scientific commentary refers to âMCAM+ brain endothelial cells contribute to neuroinflammation by recruiting pathogenic CD4+ T lymphocytesâ by Charabati et al. (https://doi.org/10.1093/ âŚ
0
2
9
Myasthenia gravis: die neuen Leitlinien fßr "Myasthene Syndrome" sind da. Neue Therapieoptionen ändern auch die Therapiekonzepte: das Ziel ist die bestmÜgliche Krankheitskontrolle (und die Herangehensweise auf Basis der Erkrankungsaktivität und -schwere).
lnkd.in
This link will take you to a page thatâs not on LinkedIn
0
0
10
Learning pathogenesis of MS via therapeutic intervention (and thus applying the strategy of reverse and refined translation): a terrific example in neuroimmunology is anti-CD20 therapyâŚ.www.pnas.org/doi/10.1073/pnas.2221544120.
1
4
20
Cerebrospinal fluid analysis is the way to better and more precisely diagnose, prognose and monitor neuropsychiatric disease manifestations. A milestone in making this an achievable goal: CSF cells can be shipped and analysed without loosing information (.
0
1
16
Multiple sclerosis and the advent of biosimilar monoclonal antibodies: ANTELOPE shows that biosimilar natalizumab matched reference in efficacy, safety, and immunogenicity for patients with RRMS in the tested randomised controlled trial.
lnkd.in
This link will take you to a page thatâs not on LinkedIn
0
5
20